C3 and hemolytic-uremic syndrome: We also compared the plasma levels of C3, C4, and soluble C5b-9 in STEC-HUS patients with those in aHUS patients and found that with similar levels of C4 and soluble C5b-9, aHUS patients demonstrate a more pronounced decrease in C3 levels (Figure 4).